연하곤란 관리 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2035년)

Dysphagia Management Market - Scope of Report

TMR's report on the global dysphagia management market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2025 to 2035. The report provides revenue of the global dysphagia management market for the period 2019-2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global dysphagia management market from 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the dysphagia management market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global dysphagia management market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global dysphagia management market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global dysphagia management market.

The report delves into the competitive landscape of the global dysphagia management market. Key players operating in the global dysphagia management market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global dysphagia management market profiled in this report.

Key Questions Answered in Global dysphagia management market Report:

• What is the sales/revenue generated by dysphagia management across all regions during the forecast period?
• What are the opportunities in the global dysphagia management market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2035?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Dysphagia Management Market - Research Objectives and Research Approach

The comprehensive report on the global dysphagia management market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global dysphagia management market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2035 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global dysphagia management market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Dysphagia Management Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Segment Definition
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Dysphagia Management Market Analysis and Forecasts, 2020-2035
  • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

• 5.1. Healthcare Expenditure across Key Regions / Countries
• 5.2. Insights on Prevalence of Dysphagia across Key Regions / Countries
• 5.3. Treatment Algorithm for Dysphagia Patients
• 5.4. Regulatory Landscape across Key Regions / Countries
• 5.5. PORTER's Five Forces Analysis
• 5.6. PESTEL Analysis
• 5.7. Key Purchase Metrics for End-users
• 5.8. Go-to-Market Strategy for New Market Entrants
• 5.9. Key Industry Events (Partnerships, Collaborations, Product approvals, Mergers & Acquisitions)
• 5.10. Benchmarking of the Products Offered by the Leading Competitors

6. Global Dysphagia Management Market Analysis and Forecasts, By Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings / Developments
• 6.3. Market Value Forecast By Product Type, 2020-2035
  • 6.3.1. Drugs
    • 6.3.1.1. Antimicrobials
    • 6.3.1.2. Proton-pump Inhibitors
    • 6.3.1.3. Others
  • 6.3.2. Feeding Tubes
    • 6.3.2.1. Nasogastric Tube (NG-tube)
    • 6.3.2.2. Gastrostomy tube (PEG, G-tube)
    • 6.3.2.3. Jejunostomy tube (PEJ, J-tube)
  • 6.3.3. Nutritional Solutions
    • 6.3.3.1. Thickeners
    • 6.3.3.2. Beverages
    • 6.3.3.3. Purees
  • 6.3.4. Others
• 6.4. Market Attractiveness By Product Type

7. Global Dysphagia Management Market Analysis and Forecasts, By Indication

• 7.1. Introduction & Definition
• 7.2. Key Findings / Developments
• 7.3. Market Value Forecast By Indication, 2020-2035
  • 7.3.1. Oral Dysphagia
  • 7.3.2. Oropharyngeal Dysphagia
  • 7.3.3. Esophageal Dysphagia
• 7.4. Market Attractiveness By Indication

8. Global Dysphagia Management Market Analysis and Forecasts, By Age Group

• 8.1. Introduction & Definition
• 8.2. Key Findings / Developments
• 8.3. Market Value Forecast By Age Group, 2020-2035
  • 8.3.1. Children
  • 8.3.2. Adults
  • 8.3.3. Geriatric
• 8.4. Market Attractiveness By Age Group

9. Global Dysphagia Management Market Analysis and Forecasts, By End-user

• 9.1. Introduction & Definition
• 9.2. Key Findings / Developments
• 9.3. Market Value Forecast By End-user, 2020-2035
  • 9.3.1. Hospitals and Ambulatory Surgical Centers
  • 9.3.2. Homecare Settings
  • 9.3.3. Long-term Care Facilities
  • 9.3.4. Outpatient Clinics
• 9.4. Market Attractiveness By End-user

10. Global Dysphagia Management Market Analysis and Forecasts, By Region

• 10.1. Key Findings
• 10.2. Market Value Forecast By Region
  • 10.2.1. North America
  • 10.2.2. Europe
  • 10.2.3. Asia Pacific
  • 10.2.4. Latin America
  • 10.2.5. Middle East & Africa
• 10.3. Market Attractiveness By Region

11. North America Dysphagia Management Market Analysis and Forecast

• 11.1. Introduction
  • 11.1.1. Key Findings
• 11.2. Market Value Forecast By Product Type, 2020-2035
  • 11.2.1. Drugs
    • 11.2.1.1. Antimicrobials
    • 11.2.1.2. Proton-pump Inhibitors
    • 11.2.1.3. Others
  • 11.2.2. Feeding Tubes
    • 11.2.2.1. Nasogastric Tube (NG-tube)
    • 11.2.2.2. Gastrostomy tube (PEG, G-tube)
    • 11.2.2.3. Jejunostomy tube (PEJ, J-tube)
  • 11.2.3. Nutritional Solutions
    • 11.2.3.1. Thickeners
    • 11.2.3.2. Beverages
    • 11.2.3.3. Purees
  • 11.2.4. Others
• 11.3. Market Value Forecast By Indication, 2020-2035
  • 11.3.1. Oral Dysphagia
  • 11.3.2. Oropharyngeal Dysphagia
  • 11.3.3. Esophageal Dysphagia
• 11.4. Market Value Forecast By Age Group, 2020-2035
  • 11.4.1. Children
  • 11.4.2. Adults
  • 11.4.3. Geriatric
• 11.5. Market Value Forecast By End-user, 2020-2035
  • 11.5.1. Hospitals and Ambulatory Surgical Centers
  • 11.5.2. Homecare Settings
  • 11.5.3. Long-term Care Facilities
  • 11.5.4. Outpatient Clinics
• 11.6. Market Value Forecast By Country, 2020-2035
  • 11.6.1. U.S.
  • 11.6.2. Canada
• 11.7. Market Attractiveness Analysis
  • 11.7.1. By Product Type
  • 11.7.2. By Indication
  • 11.7.3. By Age Group
  • 11.7.4. By End-user
  • 11.7.5. By Country

12. Europe Dysphagia Management Market Analysis and Forecast

• 12.1. Introduction
  • 12.1.1. Key Findings
• 12.2. Market Value Forecast By Product Type, 2020-2035
  • 12.2.1. Drugs
    • 12.2.1.1. Antimicrobials
    • 12.2.1.2. Proton-pump Inhibitors
    • 12.2.1.3. Others
  • 12.2.2. Feeding Tubes
    • 12.2.2.1. Nasogastric Tube (NG-tube)
    • 12.2.2.2. Gastrostomy tube (PEG, G-tube)
    • 12.2.2.3. Jejunostomy tube (PEJ, J-tube)
  • 12.2.3. Nutritional Solutions
    • 12.2.3.1. Thickeners
    • 12.2.3.2. Beverages
    • 12.2.3.3. Purees
  • 12.2.4. Others
• 12.3. Market Value Forecast By Indication, 2020-2035
  • 12.3.1. Oral Dysphagia
  • 12.3.2. Oropharyngeal Dysphagia
  • 12.3.3. Esophageal Dysphagia
• 12.4. Market Value Forecast By Age Group, 2020-2035
  • 12.4.1. Children
  • 12.4.2. Adults
  • 12.4.3. Geriatric
• 12.5. Market Value Forecast By End-user, 2020-2035
  • 12.5.1. Hospitals and Ambulatory Surgical Centers
  • 12.5.2. Homecare Settings
  • 12.5.3. Long-term Care Facilities
  • 12.5.4. Outpatient Clinics
• 12.6. Market Value Forecast By Country / Sub-region, 2020-2035
  • 12.6.1. Germany
  • 12.6.2. U.K.
  • 12.6.3. France
  • 12.6.4. Spain
  • 12.6.5. Italy
  • 12.6.6. Rest of Europe
• 12.7. Market Attractiveness Analysis
  • 12.7.1. By Product Type
  • 12.7.2. By Indication
  • 12.7.3. By Age Group
  • 12.7.4. By End-user
  • 12.7.5. By Country / Sub-region

13. Asia Pacific Dysphagia Management Market Analysis and Forecast

• 13.1. Introduction
  • 13.1.1. Key Findings
• 13.2. Market Value Forecast By Product Type, 2020-2035
  • 13.2.1. Drugs
    • 13.2.1.1. Antimicrobials
    • 13.2.1.2. Proton-pump Inhibitors
    • 13.2.1.3. Others
  • 13.2.2. Feeding Tubes
    • 13.2.2.1. Nasogastric Tube (NG-tube)
    • 13.2.2.2. Gastrostomy tube (PEG, G-tube)
    • 13.2.2.3. Jejunostomy tube (PEJ, J-tube)
  • 13.2.3. Nutritional Solutions
    • 13.2.3.1. Thickeners
    • 13.2.3.2. Beverages
    • 13.2.3.3. Purees
  • 13.2.4. Others
• 13.3. Market Value Forecast By Indication, 2020-2035
  • 13.3.1. Oral Dysphagia
  • 13.3.2. Oropharyngeal Dysphagia
  • 13.3.3. Esophageal Dysphagia
• 13.4. Market Value Forecast By Age Group, 2020-2035
  • 13.4.1. Children
  • 13.4.2. Adults
  • 13.4.3. Geriatric
• 13.5. Market Value Forecast By End-user, 2020-2035
  • 13.5.1. Hospitals and Ambulatory Surgical Centers
  • 13.5.2. Homecare Settings
  • 13.5.3. Long-term Care Facilities
  • 13.5.4. Outpatient Clinics
• 13.6. Market Value Forecast By Country / Sub-region, 2020-2035
  • 13.6.1. China
  • 13.6.2. Japan
  • 13.6.3. India
  • 13.6.4. Australia & New Zealand
  • 13.6.5. Rest of Asia Pacific
• 13.7. Market Attractiveness Analysis
  • 13.7.1. By Product Type
  • 13.7.2. By Indication
  • 13.7.3. By Age Group
  • 13.7.4. By End-user
  • 13.7.5. By Country / Sub-region

14. Latin America Dysphagia Management Market Analysis and Forecast

• 14.1. Introduction
  • 14.1.1. Key Findings
• 14.2. Market Value Forecast By Product Type, 2020-2035
  • 14.2.1. Drugs
    • 14.2.1.1. Antimicrobials
    • 14.2.1.2. Proton-pump Inhibitors
    • 14.2.1.3. Others
  • 14.2.2. Feeding Tubes
    • 14.2.2.1. Nasogastric Tube (NG-tube)
    • 14.2.2.2. Gastrostomy tube (PEG, G-tube)
    • 14.2.2.3. Jejunostomy tube (PEJ, J-tube)
  • 14.2.3. Nutritional Solutions
    • 14.2.3.1. Thickeners
    • 14.2.3.2. Beverages
    • 14.2.3.3. Purees
  • 14.2.4. Others
• 14.3. Market Value Forecast By Indication, 2020-2035
  • 14.3.1. Oral Dysphagia
  • 14.3.2. Oropharyngeal Dysphagia
  • 14.3.3. Esophageal Dysphagia
• 14.4. Market Value Forecast By Age Group, 2020-2035
  • 14.4.1. Children
  • 14.4.2. Adults
  • 14.4.3. Geriatric
• 14.5. Market Value Forecast By End-user, 2020-2035
  • 14.5.1. Hospitals and Ambulatory Surgical Centers
  • 14.5.2. Homecare Settings
  • 14.5.3. Long-term Care Facilities
  • 14.5.4. Outpatient Clinics
• 14.6. Market Value Forecast By Country / Sub-region, 2020-2035
  • 14.6.1. Brazil
  • 14.6.2. Mexico
  • 14.6.3. Rest of Latin America
• 14.7. Market Attractiveness Analysis
  • 14.7.1. By Product Type
  • 14.7.2. By Indication
  • 14.7.3. By Age Group
  • 14.7.4. By End-user
  • 14.7.5. By Country / Sub-region

15. Middle East & Africa Dysphagia Management Market Analysis and Forecast

• 15.1. Introduction
  • 15.1.1. Key Findings
• 15.2. Market Value Forecast By Product Type, 2020-2035
  • 15.2.1. Drugs
    • 15.2.1.1. Antimicrobials
    • 15.2.1.2. Proton-pump Inhibitors
    • 15.2.1.3. Others
  • 15.2.2. Feeding Tubes
    • 15.2.2.1. Nasogastric Tube (NG-tube)
    • 15.2.2.2. Gastrostomy tube (PEG, G-tube)
    • 15.2.2.3. Jejunostomy tube (PEJ, J-tube)
  • 15.2.3. Nutritional Solutions
    • 15.2.3.1. Thickeners
    • 15.2.3.2. Beverages
    • 15.2.3.3. Purees
  • 15.2.4. Others
• 15.3. Market Value Forecast By Indication, 2020-2035
  • 15.3.1. Oral Dysphagia
  • 15.3.2. Oropharyngeal Dysphagia
  • 15.3.3. Esophageal Dysphagia
• 15.4. Market Value Forecast By Age Group, 2020-2035
  • 15.4.1. Children
  • 15.4.2. Adults
  • 15.4.3. Geriatric
• 15.5. Market Value Forecast By End-user, 2020-2035
  • 15.5.1. Hospitals and Ambulatory Surgical Centers
  • 15.5.2. Homecare Settings
  • 15.5.3. Long-term Care Facilities
  • 15.5.4. Outpatient Clinics
• 15.6. Market Value Forecast By Country / Sub-region, 2020-2035
  • 15.6.1. GCC Countries
  • 15.6.2. South Africa
  • 15.6.3. Rest of Middle East & Africa
• 15.7. Market Attractiveness Analysis
  • 15.7.1. By Product Type
  • 15.7.2. By Indication
  • 15.7.3. By Age Group
  • 15.7.4. By End-user
  • 15.7.5. By Country / Sub-region

16. Competition Landscape

• 16.1. Market Player - Competition Matrix (By Tier and Size of companies)
• 16.2. Market Share Analysis By Company (2024)
• 16.3. Company Profiles
  • 16.3.1. AstraZeneca
    • 16.3.1.1. Company Overview
    • 16.3.1.2. Financial Overview
    • 16.3.1.3. Product Portfolio
    • 16.3.1.4. Business Strategies
    • 16.3.1.5. Recent Developments
  • 16.3.2. Bayer AG
    • 16.3.2.1. Company Overview
    • 16.3.2.2. Financial Overview
    • 16.3.2.3. Product Portfolio
    • 16.3.2.4. Business Strategies
    • 16.3.2.5. Recent Developments
  • 16.3.3. Pfizer, Inc.
    • 16.3.3.1. Company Overview
    • 16.3.3.2. Financial Overview
    • 16.3.3.3. Product Portfolio
    • 16.3.3.4. Business Strategies
    • 16.3.3.5. Recent Developments
  • 16.3.4. Takeda Pharmaceutical Company Limited
    • 16.3.4.1. Company Overview
    • 16.3.4.2. Financial Overview
    • 16.3.4.3. Product Portfolio
    • 16.3.4.4. Business Strategies
    • 16.3.4.5. Recent Developments
  • 16.3.5. Abbott
    • 16.3.5.1. Company Overview
    • 16.3.5.2. Financial Overview
    • 16.3.5.3. Product Portfolio
    • 16.3.5.4. Business Strategies
    • 16.3.5.5. Recent Developments
  • 16.3.6. Dr. Reddy's Laboratories Ltd.
    • 16.3.6.1. Company Overview
    • 16.3.6.2. Financial Overview
    • 16.3.6.3. Product Portfolio
    • 16.3.6.4. Business Strategies
    • 16.3.6.5. Recent Developments
  • 16.3.7. Narang Medical Limited
    • 16.3.7.1. Company Overview
    • 16.3.7.2. Financial Overview
    • 16.3.7.3. Product Portfolio
    • 16.3.7.4. Business Strategies
    • 16.3.7.5. Recent Developments
  • 16.3.8. Advin Health Care
    • 16.3.8.1. Company Overview
    • 16.3.8.2. Financial Overview
    • 16.3.8.3. Product Portfolio
    • 16.3.8.4. Business Strategies
    • 16.3.8.5. Recent Developments
  • 16.3.9. Cardinal Health
    • 16.3.9.1. Company Overview
    • 16.3.9.2. Financial Overview
    • 16.3.9.3. Product Portfolio
    • 16.3.9.4. Business Strategies
    • 16.3.9.5. Recent Developments
  • 16.3.10. B. Braun SE
    • 16.3.10.1. Company Overview
    • 16.3.10.2. Financial Overview
    • 16.3.10.3. Product Portfolio
    • 16.3.10.4. Business Strategies
    • 16.3.10.5. Recent Developments
  • 16.3.11. Kent Precision Foods Group, Inc.
    • 16.3.11.1. Company Overview
    • 16.3.11.2. Financial Overview
    • 16.3.11.3. Product Portfolio
    • 16.3.11.4. Business Strategies
    • 16.3.11.5. Recent Developments
  • 16.3.12. Fresenius Kabi Ltd
    • 16.3.12.1. Company Overview
    • 16.3.12.2. Financial Overview
    • 16.3.12.3. Product Portfolio
    • 16.3.12.4. Business Strategies
    • 16.3.12.5. Recent Developments
  • 16.3.13. Phagenesis Limited
    • 16.3.13.1. Company Overview
    • 16.3.13.2. Financial Overview
    • 16.3.13.3. Product Portfolio
    • 16.3.13.4. Business Strategies
    • 16.3.13.5. Recent Developments
  • 16.3.14. Nestle Health Science
    • 16.3.14.1. Company Overview
    • 16.3.14.2. Financial Overview
    • 16.3.14.3. Product Portfolio
    • 16.3.14.4. Business Strategies
    • 16.3.14.5. Recent Developments
  • 16.3.15. Cadila Pharmaceuticals
    • 16.3.15.1. Company Overview
    • 16.3.15.2. Financial Overview
    • 16.3.15.3. Product Portfolio
    • 16.3.15.4. Business Strategies
    • 16.3.15.5. Recent Developments
  • 16.3.16. Alcor Scientific
    • 16.3.16.1. Company Overview
    • 16.3.16.2. Financial Overview
    • 16.3.16.3. Product Portfolio
    • 16.3.16.4. Business Strategies
    • 16.3.16.5. Recent Developments
  • 16.3.17. Avanos Medical, Inc.
    • 16.3.17.1. Company Overview
    • 16.3.17.2. Financial Overview
    • 16.3.17.3. Product Portfolio
    • 16.3.17.4. Business Strategies
    • 16.3.17.5. Recent Developments